Sana Biotechnology Inc (SANA)

$4.63 -0.50 (-9.75%)
Market Cap 1.37B
Revenue (ttm) 0.00
Net Income (ttm) -266.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 5,075,300
Avg Vol 5,344,542
Day's Range N/A - N/A
Shares Out 266.37M
Stochastic %K 83%
Beta 1.95
Analysts Strong Sell
Price Target $8.57

Company Profile

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline consist of UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes; SC451, a HIP-modi...

Industry: Biotechnology
Sector: Healthcare
Phone: 206 701 7914
Address:
188 East Blaine Street, Suite 400, Seattle, United States
Esau815
Esau815 Dec. 9 at 3:27 AM
$SANA For those who are new to the board, BrionH is--by far--the most valuable resource on this forum. A T1D patient, he is beyond passionate to find a cure while at the same time realistic about the unsolved challenges that have yet to be conquered. He is generous with his information and knows more about T1D and $SANA than anyone posting.
0 · Reply
Brianum2011
Brianum2011 Dec. 8 at 5:35 PM
$SANA Why the drop?
1 · Reply
LunarPixel87
LunarPixel87 Dec. 8 at 2:30 PM
$SANA Nature biotechnology is an extremely good/respectable journal. Among the best in the world, reserved for significant biotech advances. Not an easy feat to publish there
0 · Reply
JerryMalone32
JerryMalone32 Dec. 8 at 2:22 PM
$SANA press release just published on Nature Journal article. For those who follow Casgevy and/or Lyfgenia / Zynteglo, the sickle cell / Beta Thalessemia gene therapies of $VRTX $CRSP and bluebird bio, this technology has applicability there.
0 · Reply
LoveRetailFroth
LoveRetailFroth Dec. 8 at 1:00 PM
$RXRX Good Morning 💎s all ☕️ 🚀 $SANA $AMLX
0 · Reply
jamesmckevitt
jamesmckevitt Dec. 8 at 10:04 AM
$SANA imagine if he hit double digits EoY
0 · Reply
OliveGardenCPA
OliveGardenCPA Dec. 8 at 3:17 AM
$SANA we finna see $15.00 this week!!!
0 · Reply
sellthetop
sellthetop Dec. 8 at 2:06 AM
$SANA $10 dollar stock incoming...
0 · Reply
JerryMalone32
JerryMalone32 Dec. 7 at 4:49 PM
$SANA published friday in Nature Journal. https://www.nature.com/articles/s41587-025-02915-2.pdf
1 · Reply
GSP
GSP Dec. 7 at 4:45 PM
Was Friday just a rest day before $SANA continues higher? .
0 · Reply
Latest News on SANA
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Dec 8, 2025, 9:00 AM EST - 23 hours ago

Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform

Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 3, 2025, 5:03 PM EST - 5 days ago

Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 2, 2025, 5:43 PM EST - 6 days ago

Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Sana Biotechnology to Present at December 2025 Investor Conferences

Nov 24, 2025, 4:05 PM EST - 14 days ago

Sana Biotechnology to Present at December 2025 Investor Conferences

Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D

Oct 16, 2025, 5:09 PM EDT - 7 weeks ago

Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D

Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight

Oct 16, 2025, 4:18 PM EDT - 7 weeks ago

Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight

Sana Biotech Stock — The Next '100-Bagger'?

Oct 15, 2025, 12:15 PM EDT - 7 weeks ago

Sana Biotech Stock — The Next '100-Bagger'?

Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 4:34 PM EDT - 3 months ago

Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sep 5, 2025, 1:42 AM EDT - 3 months ago

Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 2, 2025, 10:03 PM EDT - 3 months ago

Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

Aug 28, 2025, 8:00 AM EDT - 3 months ago

IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies

FHTX IQV MRNA

Sana Biotechnology to Present at September 2025 Investor Conferences

Aug 26, 2025, 4:05 PM EDT - 3 months ago

Sana Biotechnology to Present at September 2025 Investor Conferences

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Aug 20, 2025, 4:05 PM EDT - 3 months ago

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued

Aug 8, 2025, 2:58 PM EDT - 4 months ago

Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued

Sana Biotechnology Announces Pricing of Public Offering

Aug 6, 2025, 11:24 PM EDT - 4 months ago

Sana Biotechnology Announces Pricing of Public Offering

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Aug 6, 2025, 4:38 PM EDT - 4 months ago

Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 6, 2025, 7:00 AM EDT - 4 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

MCRB

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Aug 4, 2025, 11:35 AM EDT - 4 months ago

Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Jun 23, 2025, 10:05 AM EDT - 6 months ago

Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

Two Biotech Stocks Poised For Big Moves On Monday

Jun 23, 2025, 7:39 AM EDT - 6 months ago

Two Biotech Stocks Poised For Big Moves On Monday

LCTX

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Jun 9, 2025, 4:05 PM EDT - 6 months ago

Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions

Sana Biotechnology to Present at June 2025 Investor Conferences

May 28, 2025, 4:05 PM EDT - 6 months ago

Sana Biotechnology to Present at June 2025 Investor Conferences

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

May 19, 2025, 3:10 PM EDT - 7 months ago

Sana: HIP-Modified Islet Cells To Possibly Change Scope Of Type 1 Diabetes Treatment

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

May 19, 2025, 11:57 AM EDT - 7 months ago

The End Of The Diabetes Industry? This Small Cap Could Upend The Business Models of Pharma Giants

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

May 14, 2025, 2:50 PM EDT - 7 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

May 12, 2025, 4:05 PM EDT - 7 months ago

Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

May 8, 2025, 5:45 AM EDT - 7 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 20, 2025 in Sana Biotechnology, Inc. Lawsuit - SANA

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Apr 19, 2025, 8:10 AM EDT - 8 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sana Biotechnology

Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421

Mar 24, 2025, 11:45 PM EDT - 9 months ago

Sana Biotechnology: High-Risk High-Reward With Breakthrough UP421

Esau815
Esau815 Dec. 9 at 3:27 AM
$SANA For those who are new to the board, BrionH is--by far--the most valuable resource on this forum. A T1D patient, he is beyond passionate to find a cure while at the same time realistic about the unsolved challenges that have yet to be conquered. He is generous with his information and knows more about T1D and $SANA than anyone posting.
0 · Reply
Brianum2011
Brianum2011 Dec. 8 at 5:35 PM
$SANA Why the drop?
1 · Reply
LunarPixel87
LunarPixel87 Dec. 8 at 2:30 PM
$SANA Nature biotechnology is an extremely good/respectable journal. Among the best in the world, reserved for significant biotech advances. Not an easy feat to publish there
0 · Reply
JerryMalone32
JerryMalone32 Dec. 8 at 2:22 PM
$SANA press release just published on Nature Journal article. For those who follow Casgevy and/or Lyfgenia / Zynteglo, the sickle cell / Beta Thalessemia gene therapies of $VRTX $CRSP and bluebird bio, this technology has applicability there.
0 · Reply
LoveRetailFroth
LoveRetailFroth Dec. 8 at 1:00 PM
$RXRX Good Morning 💎s all ☕️ 🚀 $SANA $AMLX
0 · Reply
jamesmckevitt
jamesmckevitt Dec. 8 at 10:04 AM
$SANA imagine if he hit double digits EoY
0 · Reply
OliveGardenCPA
OliveGardenCPA Dec. 8 at 3:17 AM
$SANA we finna see $15.00 this week!!!
0 · Reply
sellthetop
sellthetop Dec. 8 at 2:06 AM
$SANA $10 dollar stock incoming...
0 · Reply
JerryMalone32
JerryMalone32 Dec. 7 at 4:49 PM
$SANA published friday in Nature Journal. https://www.nature.com/articles/s41587-025-02915-2.pdf
1 · Reply
GSP
GSP Dec. 7 at 4:45 PM
Was Friday just a rest day before $SANA continues higher? .
0 · Reply
democratsaredisease
democratsaredisease Dec. 6 at 8:57 PM
$BACQ $BBAI $FROG $SANA $SPY report this spammer
0 · Reply
GSP
GSP Dec. 6 at 8:55 PM
$SPY $BBAI $BACQ $FROG $SANA
0 · Reply
BriOnH
BriOnH Dec. 6 at 8:01 PM
$SANA As a new wave of investors have come in, it might be a good time to remember "Diabetes" is a very large umbrella of which all will not be fixed by Sana. Diabetes Types: Type 1 (and type 1.5 LADA) = about 8% of of the total population of diabetics, around 2 million of us in the US and is what Sana is currently attempting to cure. Type 2 = 90% of people living with diabetes are Type 2 and has arguably become an epidemic, Sana will have little to no effect on this type. About 38 millions people in the US have Type 2. Other types, Gestational, Type 3, Monogenic, Chemical induced (ie; tacrolimus the immunosuppression drug) is about 3% of diabetics and could help roughly half of these. I don't post this to be condescending or disrespectful, I do it for the investors that want to know what they are investing in, and not be a blind bull. Good luck to us all.
1 · Reply
LunarPixel87
LunarPixel87 Dec. 5 at 9:31 PM
$SANA good riddance to the paper hands, the naysayers, and the doubters. The data is already here and I follow the data. Hi ho $10+ on the way to T1D cure!
2 · Reply
rtaker
rtaker Dec. 5 at 5:11 PM
$SANA Starter [email protected]
0 · Reply
LoveRetailFroth
LoveRetailFroth Dec. 5 at 2:18 PM
$RXRX $RXRX Great Morning 💎s ☕️ $SANA $AMLX I am holding for 12 months for $30 plus🚀
0 · Reply
mwbtrader
mwbtrader Dec. 5 at 5:26 AM
$SANA if these guys fix diabetes it would be massive
0 · Reply
Scrapps64
Scrapps64 Dec. 5 at 5:09 AM
$SANA
0 · Reply
Lowboy9191
Lowboy9191 Dec. 5 at 12:39 AM
$SANA
0 · Reply
dixiebull
dixiebull Dec. 4 at 9:55 PM
$OCUL got to 13, so now we want 12.50 to break for 13 and 13.50 $SANA ran to 5.49, see if 5 holds for 5.50 and 6 $DGXX made it to 3.83, if that 4 can break it can get 4.50/5 $USAR beast today to 17.73, if momo keep sin it can get 18 to 20 $SERV made my 13 target from watchlist so ow we want 12.50 to hold on a dip for 13 to 13.50/14
0 · Reply
dixiebull
dixiebull Dec. 4 at 9:55 PM
$GSIT ran to 7.20, see if 7 holds now for 7.50 and 8 $PMI pushed to 4.16, see if 3 can hold for another ove to 3.50 and 4 $NUKK got 7.44, see if 7 holds for a move to 8 $QCLS ran to 8 here afterhours, see if 7/65 holds on a dip for a move to 8.50/9 $SANA ran to 5.49, see if 5 can hold for 5.50 and 6
0 · Reply